4-[2-(aminomethyl)-1H-benzimidazol-4-yl]-1-N-(1-aminopropan-2-yl)-3-(2H-tetrazol-5-yl)benzene-1,2-disulfonamide
C18H22N10O4S2 — CID 135311369
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[2-(aminomethyl)-1H-benzimidazol-4-yl]-1-N-(1-aminopropan-2-yl)-3-(2H-tetrazol-5-yl)benzene-1,2-disulfonamide
4-[2-(aminomethyl)-1H-benzimidazol-4-yl]-1-N-(1-aminopropan-2-yl)-3-(2H-tetrazol-5-yl)benzene-1,2-disulfonamide (PubChem CID 135311369) has the molecular formula C18H22N10O4S2 and a molecular weight of 506.57 g/mol. Its IUPAC name is 4-[2-(aminomethyl)-1H-benzimidazol-4-yl]-1-N-(1-aminopropan-2-yl)-3-(2H-tetrazol-5-yl)benzene-1,2-disulfonamide.
Molecular Properties
| Compound Name | 4-[2-(aminomethyl)-1H-benzimidazol-4-yl]-1-N-(1-aminopropan-2-yl)-3-(2H-tetrazol-5-yl)benzene-1,2-disulfonamide |
|---|---|
| PubChem CID | 135311369 |
| Molecular Formula | C18H22N10O4S2 |
| Molecular Weight | 506.57 g/mol |
| Exact Mass | 506.13 |
| IUPAC Name | 4-[2-(aminomethyl)-1H-benzimidazol-4-yl]-1-N-(1-aminopropan-2-yl)-3-(2H-tetrazol-5-yl)benzene-1,2-disulfonamide |
| SMILES | CC(CN)NS(=O)(=O)c1ccc(-c2cccc3[nH]c(CN)nc23)c(-c2nn[nH]n2)c1S(N)(=O)=O |
| InChI | InChI=1S/C18H22N10O4S2/c1-9(7-19)26-34(31,32)13-6-5-10(11-3-2-4-12-16(11)23-14(8-20)22-12)15(17(13)33(21,29)30)18-24-27-28-25-18/h2-6,9,26H,7-8,19-20H2,1H3,(H,22,23)(H2,21,29,30)(H,24,25,27,28) |
| InChIKey | OQTUJIHTSYMXJD-UHFFFAOYSA-N |
| XLogP | -0.86 |
| TPSA | 241.51 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 506.57 |
| LogP ≤ 5 | -0.86 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135311369 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.